Details of the Drug

General Information of Drug (ID: DM2AZPP)

Drug Name
Hepzato
Indication
Disease Entry ICD 11 Status REF
Uveal Melanoma 2D0Y Phase 3 [1]
Cross-matching ID
PubChem CID
9927978
TTD ID
DFB62M
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 ClinicalTrials.gov (NCT05022901) An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma. U.S.National Institutes of Health.